Market Cap (In CNY)
2.95 Billion
Revenue (In CNY)
2.06 Billion
Net Income (In CNY)
43.55 Million
Avg. Volume
11.36 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.75-6.33
- PE
- -
- EPS
- -
- Beta Value
- 0.647
- ISIN
- CNE0000010L8
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jingliang Li
- Employee Count
- -
- Website
- https://www.taloph.com
- Ipo Date
- 1999-11-05
- Details
- Henan Taloph Pharmaceutical Stock Co., Ltd. researches, produces, and sells Chinese and western medicines in China. It primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and other forms. The company's principal products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, pazufloxacin mesylate sodium chloride injections, and various infusion products. It serves hospitals, pharmacies, and patients. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. Henan Taloph Pharmaceutical Stock Co., Ltd. is based in Zhengzhou, China.
More Stocks
-
EMIL-PREFFastighetsbolaget Emilshus AB (publ)
EMIL-PREF
-
MDI
-
CNNRF
-
6209
-
COFECoffee Inc.
COFE
-
MAGNAELQMagna Electro Castings Limited
MAGNAELQ
-
ALUR
-
CHGZ